Procurement Summary
Country: Kazakhstan
Summary: Hospital Medicines, Amt: 925775.00
Deadline: 13 Mar 2026
Posting Date: 13 Mar 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 137690561
Document Ref. No.: 16548800-1
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: KZT 925775.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Lots: Mirtel (Mirtazapine) 30 mg, No. 30 Composition One tablet contains the active substance - mirtazapine 30 mg, excipients: lactose monohydrate, corn starch, hydroxypropylcellulose, colloidal anhydrous silicon dioxide, magnesium stearate, vegetable shell: polyvinyl alcohol, lecithin (E322), titanium dioxide (E171), macrogol 3350, talc (E553 b), yellow iron oxide (E172), red iron oxide (E172), black iron oxide (E172). | Brintellix (Vortioxetine) 10 mg, No. 28 Composition One tablet, film-coated, contains the active substance - vortioxetine (in the form of vortioxetine hydrobromide) 5 mg, 10 mg or 20 mg; excipients - mannitol, microcrystalline cellulose, hydroxypropylcellulose, sodium carboxymethyl starch (type A), magnesium stearate; tablet shell - hypromellose, macrogol 400, titanium dioxide (E171), red iron oxide (E172) (for a dosage of 5 mg); hypromellose, macrogol 400, titanium dioxide (E171), iron oxide yellow (E172) (for a dosage of 10 mg); hypromellose, macrogol 400, titanium dioxide (E171), iron oxide red (E172) (for a dosage of 20 mg) | Brintellix (Vortioxetine) 5 mg, No. 28 Composition One film-coated tablet contains the active substance - vortioxetine (in the form of vortioxetine hydrobromide) 5 mg, 10 mg or 20 mg; excipients - mannitol, microcrystalline cellulose, hydroxypropylcellulose, sodium carboxymethyl starch (type A), magnesium stearate; tablet shell - hypromellose, macrogol 400, tit...
Documents
Tender Notice